Brief: Neurosense Announces Third Quarter 2022 Financial Results And Provides Business Update

Neurosense Therapeutics

01/12/2022 16:03

Dec 1 (Reuters) - Neurosense Therapeutics Ltd  NRSN.O :
    * NEUROSENSE THERAPEUTICS LTD - 9-MONTH LOSS PER SHARE $0.80
    * NEUROSENSE ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
    * NEUROSENSE THERAPEUTICS LTD - AS OF SEPTEMBER 30, 2022,
NEUROSENSE HAD CASH AND SHORT-TERM DEPOSITS OF $8.44 MILLION
    * NEUROSENSE THERAPEUTICS LTD - BELIEVES THAT CASH RESOURCES
WILL
BE SUFFICIENT TO CONTINUE DEVELOPMENT OF CO'S PRODUCT INTO Q4 OF
2023

Further company coverage:  NRSN.O 
 ((Reuters.Briefs@thomsonreuters.com;))